Phreesia, Inc. (NYSE:PHR) General Counsel Sells $123,336.50 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 4,585 shares of the stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $26.90, for a total transaction of $123,336.50. Following the transaction, the general counsel now directly owns 154,552 shares of the company’s stock, valued at approximately $4,157,448.80. This trade represents a 2.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Phreesia Price Performance

Shares of PHR opened at $27.24 on Monday. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of -18.53 and a beta of 0.94. The firm’s fifty day simple moving average is $23.54 and its 200-day simple moving average is $22.83. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $29.16. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same period in the previous year, the business earned ($0.58) EPS. Phreesia’s revenue for the quarter was up 16.6% on a year-over-year basis. Equities analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Hedge Funds Weigh In On Phreesia

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Deerfield Management Company L.P. Series C purchased a new stake in shares of Phreesia during the 2nd quarter worth approximately $4,078,000. Champlain Investment Partners LLC raised its stake in Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after acquiring an additional 97,847 shares in the last quarter. Sei Investments Co. lifted its position in Phreesia by 135.3% in the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after acquiring an additional 95,058 shares during the last quarter. Squarepoint Ops LLC boosted its stake in Phreesia by 56.3% in the second quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after acquiring an additional 90,215 shares in the last quarter. Finally, State Street Corp grew its holdings in shares of Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares during the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

PHR has been the subject of several research reports. Truist Financial lifted their target price on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Citigroup boosted their price objective on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. JMP Securities restated a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price target for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Finally, Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of Phreesia in a research report on Friday, January 10th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia has an average rating of “Buy” and a consensus price target of $31.00.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.